 | Up a level |
Bahrambeigi, S and Seifi, L and Shafiei Irannejad, V and Sohrabi, F and Molaparast, M and Fani, S and Faraji, A.R (2020) Targeting PPAR ligands as possible approaches for metabolic reprogramming of T cells in cancer immunotherapy. Immunology Letters, 220. pp. 32-37.
Bahrambeigi, S and Shafiei Irannejad, V and Sanajou, D (2019) Major fundamental factors hindering immune system in defense against tumor cells: The link between insufficiency of innate immune responses, metabolism, and neurotransmitters with effector immune cells disability. Immunology Letters, 212. pp. 81-87.
Bahrambeigi, S and Shafiei Irannejad, V and Rahimi, M and Yousefi, B (2019) Metformin; an old antidiabetic drug with new potentials in bone disorders. Biomedicine & Pharmacotherapy, 109. pp. 1593-1601.
